191 related articles for article (PubMed ID: 27191122)
21. Significantly improved neurocognitive function in major depressive disorders 6 weeks after ECT.
Mohn C; Rund BR
J Affect Disord; 2016 Sep; 202():10-5. PubMed ID: 27253211
[TBL] [Abstract][Full Text] [Related]
22. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
Freire TF; Fleck MP; da Rocha NS
Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
[TBL] [Abstract][Full Text] [Related]
23. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
[TBL] [Abstract][Full Text] [Related]
24. Neurognitive function and symptom remission 2 years after ECT in major depressive disorders.
Mohn C; Rund BR
J Affect Disord; 2019 Mar; 246():368-375. PubMed ID: 30597298
[TBL] [Abstract][Full Text] [Related]
25. The acute and medium-term effects of treatment with electroconvulsive therapy on memory in patients with major depressive disorder.
Maric NP; Stojanovic Z; Andric S; Soldatovic I; Dolic M; Spiric Z
Psychol Med; 2016 Mar; 46(4):797-806. PubMed ID: 26493090
[TBL] [Abstract][Full Text] [Related]
26. Genetic influence of COMT and BDNF gene polymorphisms on resilience in healthy college students.
Kang JI; Kim SJ; Song YY; Namkoong K; An SK
Neuropsychobiology; 2013; 68(3):174-80. PubMed ID: 24107543
[TBL] [Abstract][Full Text] [Related]
27. The cognitive effects of electroconvulsive therapy in community settings.
Sackeim HA; Prudic J; Fuller R; Keilp J; Lavori PW; Olfson M
Neuropsychopharmacology; 2007 Jan; 32(1):244-54. PubMed ID: 16936712
[TBL] [Abstract][Full Text] [Related]
28. Influence of BDNF and COMT polymorphisms on emotional decision making.
Kang JI; Namkoong K; Ha RY; Jhung K; Kim YT; Kim SJ
Neuropharmacology; 2010 Jun; 58(7):1109-13. PubMed ID: 20153759
[TBL] [Abstract][Full Text] [Related]
29. Interaction of BDNF and COMT polymorphisms on paired-associative stimulation-induced cortical plasticity.
Witte AV; Kürten J; Jansen S; Schirmacher A; Brand E; Sommer J; Flöel A
J Neurosci; 2012 Mar; 32(13):4553-61. PubMed ID: 22457502
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy.
Moirand R; Galvao F; Lecompte M; Poulet E; Haesebaert F; Brunelin J
Psychiatry Res; 2018 Jan; 259():476-481. PubMed ID: 29149717
[TBL] [Abstract][Full Text] [Related]
31. A within-subject comparison of propofol and methohexital anesthesia for electroconvulsive therapy.
Vaidya PV; Anderson EL; Bobb A; Pulia K; Jayaram G; Reti I
J ECT; 2012 Mar; 28(1):14-9. PubMed ID: 22330701
[TBL] [Abstract][Full Text] [Related]
32. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
33. The Clinical Practice of Assessing Cognitive Function in Adults Receiving Electroconvulsive Therapy: Whom Are We Missing?
Obbels J; Vanbrabant K; Bouckaert F; Verwijk E; Sienaert P
J ECT; 2016 Jun; 32(2):99-103. PubMed ID: 26421675
[TBL] [Abstract][Full Text] [Related]
34. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
Falconer DW; Cleland J; Fielding S; Reid IC
Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
[TBL] [Abstract][Full Text] [Related]
35. The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs.
Alonso P; López-Solà C; Gratacós M; Fullana MA; Segalàs C; Real E; Cardoner N; Soriano-Mas C; Harrison BJ; Estivill X; Menchón JM
J Anxiety Disord; 2013 Apr; 27(3):321-7. PubMed ID: 23602946
[TBL] [Abstract][Full Text] [Related]
36. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms.
Han DH; Park DB; Choi TY; Joo SY; Lee MK; Park BR; Nishimura R; Chu CC; Renshaw PF
Neuroreport; 2008 Jul; 19(11):1155-8. PubMed ID: 18596619
[TBL] [Abstract][Full Text] [Related]
37. Effect of Functional BDNF and COMT Polymorphisms on Symptoms and Regional Brain Volume in Frontotemporal Dementia and Corticobasal Syndrome.
Huey ED; Fremont R; Manoochehri M; Gazes Y; Lee S; Cosentino S; Tierney M; Wassermann EM; Momeni P; Grafman J
J Neuropsychiatry Clin Neurosci; 2020; 32(4):362-369. PubMed ID: 32397876
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of the brain-derived neurotrophic factor and dynamics of the seizure threshold of electroconvulsive therapy.
Stephani C; Shoukier M; Ahmed R; Wolff-Menzler C
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):787-794. PubMed ID: 27787610
[TBL] [Abstract][Full Text] [Related]
39. Cognitive Performance Under Electroconvulsive Therapy (ECT) in ECT-Naive Treatment-Resistant Patients With Major Depressive Disorder.
Ziegelmayer C; Hajak G; Bauer A; Held M; Rupprecht R; Trapp W
J ECT; 2017 Jun; 33(2):104-110. PubMed ID: 28169947
[TBL] [Abstract][Full Text] [Related]
40. BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder.
Strauss J; Barr CL; George CJ; Ryan CM; King N; Shaikh S; Kovacs M; Kennedy JL
Neuromolecular Med; 2004; 5(3):181-92. PubMed ID: 15626819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
